Literature DB >> 14234114

STUDIES IN MYASTHENIA GRAVIS. 1. A CLINICAL STUDY OF 180 PATIENTS.

H J OOSTERHUIS.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID; CLASSIFICATION; EXTREMITIES; EYE MANIFESTATIONS; HYPERSENSITIVITY; HYPERTHYROIDISM; MENSTRUATION; MYASTHENIA GRAVIS; PARALYSIS, BULBAR; STATISTICS; THYMOMA

Mesh：

Year:  1964        PMID： 14234114     DOI： 10.1016/0022-510x(64)90171-6

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  26 in total

1.  Genetic associations between myasthenia gravis and the HL-A system.

Authors:  R Pirskanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

2.  Abnormal T cell receptor V gene usage in myasthenia gravis: prevalence and characterization of expanded T cell populations.

Authors:  B Y Xu; R Giscombe; A Söderlund; M Troye-Blomberg; R Pirskanen; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

3.  Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?

Authors:  D Gigliotti; A K Lefvert; M Jeddi-Tehrani; S Esin; V Hodara; R Pirskanen; H Wigzell; R Andersson
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

4.  Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications.

Authors:  A K Lefvert; K Bergström; G Matell; P O Osterman; R Pirskanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

Review 5.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

6.  The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Authors:  Ted M Burns; Mark Conaway; Donald B Sanders
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

7.  Periductal lymphocytic infiltrates in salivary glands in myasthenia gravis patients lacking Sjögren's syndrome.

Authors:  G Lindahl; A K Lefvert; E Hedfors
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

8.  Antibodies to salivary duct cells, and other autoantibodies, in patients with Sjögren's syndrome and other idiopathic autoimmune diseases.

Authors:  T E Feltkamp; A L van Rossum
Journal:  Clin Exp Immunol       Date:  1968-01       Impact factor: 4.330

9.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16

10.  [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].

Authors:  I Kalies; F Heinz; W P Kaschka; K F Druschky; J R Kalden
Journal:  Klin Wochenschr       Date:  1984-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.